- Home
- HEES vs MRUS Comparison
HEES vs MRUS Comparison
Compare HEES & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEES
- MRUS
- Stock Information
- Founded
- HEES 1961
- MRUS 2003
- Country
- HEES United States
- MRUS Netherlands
- Employees
- HEES N/A
- MRUS N/A
- Industry
- HEES Misc Corporate Leasing Services
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- HEES Industrials
- MRUS Health Care
- Exchange
- HEES Nasdaq
- MRUS Nasdaq
- Market Cap
- HEES 3.2B
- MRUS 2.9B
- IPO Year
- HEES 2006
- MRUS 2016
- Fundamental
- Price
- HEES $89.44
- MRUS $39.53
- Analyst Decision
- HEES Buy
- MRUS Strong Buy
- Analyst Count
- HEES 6
- MRUS 12
- Target Price
- HEES $69.25
- MRUS $87.92
- AVG Volume (30 Days)
- HEES 1.3M
- MRUS 658.9K
- Earning Date
- HEES 02-20-2025
- MRUS 02-26-2025
- Dividend Yield
- HEES 1.23%
- MRUS N/A
- EPS Growth
- HEES N/A
- MRUS N/A
- EPS
- HEES 3.94
- MRUS N/A
- Revenue
- HEES $1,518,307,000.00
- MRUS $35,932,000.00
- Revenue This Year
- HEES $4.55
- MRUS N/A
- Revenue Next Year
- HEES $3.91
- MRUS $57.49
- P/E Ratio
- HEES $22.72
- MRUS N/A
- Revenue Growth
- HEES 5.69
- MRUS N/A
- 52 Week Low
- HEES $40.92
- MRUS $33.60
- 52 Week High
- HEES $90.66
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- HEES 81.84
- MRUS 39.44
- Support Level
- HEES $87.70
- MRUS $38.52
- Resistance Level
- HEES $90.66
- MRUS $40.44
- Average True Range (ATR)
- HEES 1.30
- MRUS 1.97
- MACD
- HEES 4.80
- MRUS -0.10
- Stochastic Oscillator
- HEES 98.01
- MRUS 19.54
About HEES H&E Equipment Services Inc.
H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.